Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children

Blood (2024) 144 (Supplement 1): 709.

https://doi.org/10.1182/blood-2024-193644

Published: 2024

Journal Articles

Sickle Cell Genotype and Biomarkers of Endothelial Dysfunction Predict Early Kidney Disease in Patients with APOL1 High Risk Variants

Jeffrey D Lebensburger, Guolian Kang, Sara Rashkin, Rima Zahr, Malgorzata Kasztan

Blood (2024) 144 (Supplement 1): 803.

https://doi.org/10.1182/blood-2024-203474

Published: 2024

Journal Articles

The Natural History of Glomerular Hyperfiltration in Sickle Cell Disease

Rima Zahr, Shuyan Chen, Parul Rai, Jane S Hankins, Winfred C. Wang, Jeffrey D Lebensburger, Guolian Kang, Kenneth I. Ataga

Blood (2024) 144 (Supplement 1): 3886.

https://doi.org/10.1182/blood-2024-199586

Published: 2024

Journal Articles

Development of a Genetic Risk Score for Albuminuria in Pediatric Patients with Sickle Cell Anemia

Rima Zahr, Guolian Kang, Sara Rashkin, Yutaka Yasui, Csaba Kovesdy, Clifford M Takemoto, Jeffrey D. Lebensburger, Mitchell Weiss, Santosh L. Saraf, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 1141.

https://doi.org/10.1182/blood-2023-185213

Published: 2023

Journal Articles

Burden of Chronic Kidney Disease in Californians with Sickle Cell Disease

Jhaqueline Valle, Jeffrey D. Lebensburger, Pranav S Garimella, Srila Gopal

Blood (2023) 142 (Supplement 1): 3890.

https://doi.org/10.1182/blood-2023-178478

Published: 2023

Journal Articles

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update

Blood (2023) 142 (Supplement 1): 1223.

https://doi.org/10.1182/blood-2023-172819

Published: 2023

Journal Articles

Association of Elevated Tricuspid Regurgitation Velocity with Kidney and Cerebrovascular Disease in Children with Sickle Cell Disease

Chibuzo C Ilonze, Najibah Aliyu Galadanci, Dakshin Padmanabhan, Ammar Saadoon, Brandi Pernell, Jeffrey D. Lebensburger

Blood (2022) 140 (Supplement 1): 5431–5432.

https://doi.org/10.1182/blood-2022-167358

Published: 2022

Journal Articles

Natural History of Albuminuria in Pediatric Sickle Cell Anemia

Kayla Baker, Michael Ho, Chibuzo C Ilonze, Malgorzata Kasztan, Jeffrey D. Lebensburger

Blood (2022) 140 (Supplement 1): 8286–8287.

https://doi.org/10.1182/blood-2022-158290

Published: 2022

Journal Articles

The Relationship of Sleep and Pain in Pediatric Sickle Cell Disease

Dakshin Padmanabhan, Tiffany Tucker, Donna Murdaugh, Chibuzo C Ilonze, Jeffrey D. Lebensburger, S. Justin Thomas

Blood (2022) 140 (Supplement 1): 2169–2170.

https://doi.org/10.1182/blood-2022-157555

Published: 2022

Journal Articles

Diagnosis and Management of Isolated Neutropenia: A Survey of Pediatric Hematologists Oncologists

Elizabeth R Gunn, Jacquelyn M. Powers, AKM Fazlur Rahman, Christina J. Bemrich-Stolz, Stephen Mennemeyer, Jeffrey D. Lebensburger, Hope P. Wilson

Blood (2022) 140 (Supplement 1): 1219–1220.

https://doi.org/10.1182/blood-2022-156687

Published: 2022

Journal Articles

Balanced Crystalloids Versus Normal Saline in Noncritically Ill Adults with Sickle Cell Disease Admitted from the Emergency Department: A Sub-Analysis of the Salt-ED Trial

Marcus A. Carden, Jeffrey D. Lebensburger, Vimal K Derebail, Wesley H. Self

Blood (2022) 140 (Supplement 1): 2543–2544.

https://doi.org/10.1182/blood-2022-156089

Published: 2022

Journal Articles

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease

Rima Zahr, Akram Mohammed, Surabhi Naik, Daniel Faradji, Jeffrey D. Lebensburger, Kenneth I Ataga, Robert L Davis

Blood (2022) 140 (Supplement 1): 2530–2531.

https://doi.org/10.1182/blood-2022-165572

Published: 2022

Journal Articles

Vaccine Schedule Disparities Exist for Pediatric Patients with Sickle Cell Disease

Dakshin Padmanabhan, Elizabeth R Gunn, Christina J. Bemrich-Stolz, Jeffrey D. Lebensburger, Wendy Landier

Blood (2022) 140 (Supplement 1): 5137–5138.

https://doi.org/10.1182/blood-2022-156451

Published: 2022

Journal Articles

Anticoagulation Use for Secondary Prophylaxis Against Recurrent Venous Thromboembolism in Hospitalized Children: A Report from the Children's Hospital-Acquired Thrombosis (CHAT) Consortium

Hope P. Wilson, Brian Branchford, Julie Jaffray, Emily Krava, Amy Stillings, Jeffrey D. Lebensburger, Neil Goldenberg

Blood (2022) 140 (Supplement 1): 350–351.

https://doi.org/10.1182/blood-2022-170212

Published: 2022

Journal Articles

Standardizing the Diagnostic and Therapeutic Approach to Newly Diagnosed Children with ITP: Prospective Data from the ITP Consortium of North America (ICON) Quality Improvement Initiative

Hannah Elkus, Rachael F. Grace, Taylah Buissereth, Carolyn Bennett, Stacey Rifkin-Zenenberg, Elizabeth R Gunn, Jeffrey D. Lebensburger, Pablo Angulo, Monica Davini, Alexander W. Rankin, Taizo A. Nakano, Corinna L. Schultz, Ashley Pinchinat, Kirsty Hillier, Sherif M. Badawy

Blood (2022) 140 (Supplement 1): 1208–1210.

https://doi.org/10.1182/blood-2022-170067

Published: 2022

Journal Articles

International Survey of Secondary Thromboprophylaxis Practice Patterns in Pediatrics

Hope P Wilson, Rosebella Capio, Inmaculada Aban, Jeffrey D. Lebensburger, Neil Goldenberg

Blood (2021) 138 (Supplement 1): 2129.

https://doi.org/10.1182/blood-2021-151528

Published: 2021

Journal Articles

Sleep Characterization of Adolescent and Young Adult Patients with Sickle Cell Disease Using the Pittsburgh Sleep Quality Index

Gabrielle F Gloston, S. Justin Thomas, Sarah Maxwell, Jeffrey D. Lebensburger, Julie Kanter, Alyssa M Schlenz

Blood (2021) 138 (Supplement 1): 1954.

https://doi.org/10.1182/blood-2021-151944

Published: 2021

Journal Articles

A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Effect of Crizanlizumab and Standard of Care (SoC) Versus Standard of Care Alone on Renal Function in Patients with Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)

Santosh L. Saraf, Kenneth I. Ataga, Vimal K. Derebail, Claire C. Sharpe, Adlette Inati, Jeffrey D. Lebensburger, Laurie DeBonnett, Yifan Zhang, Pablo Bartolucci

Blood (2021) 138 (Supplement 1): 3096.

https://doi.org/10.1182/blood-2021-149849

Published: 2021

Journal Articles

Quantitative Assessment of Physical Activity in Adults with Sickle Cell Disease

Foluso Joy Ogunsile, Nicky Harris, David T Redden, Jeffrey D. Lebensburger, Julie Kanter

Blood (2021) 138 (Supplement 1): 3102.

https://doi.org/10.1182/blood-2021-154451

Published: 2021

Journal Articles

Outcomes of Patients with Sickle Cell Disease and Eskd in the Usrds Registry

Rima Zahr, Marianne McPherson Yee, Kenneth I. Ataga, Jeffrey Winer, Jeffrey D. Lebensburger

Blood (2021) 138 (Supplement 1): 4056.

https://doi.org/10.1182/blood-2021-152989

Published: 2021

NARROW

Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children

Sickle Cell Genotype and Biomarkers of Endothelial Dysfunction Predict Early Kidney Disease in Patients with APOL1 High Risk Variants

The Natural History of Glomerular Hyperfiltration in Sickle Cell Disease

Development of a Genetic Risk Score for Albuminuria in Pediatric Patients with Sickle Cell Anemia

Burden of Chronic Kidney Disease in Californians with Sickle Cell Disease

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update

Association of Elevated Tricuspid Regurgitation Velocity with Kidney and Cerebrovascular Disease in Children with Sickle Cell Disease

Natural History of Albuminuria in Pediatric Sickle Cell Anemia

The Relationship of Sleep and Pain in Pediatric Sickle Cell Disease

Diagnosis and Management of Isolated Neutropenia: A Survey of Pediatric Hematologists Oncologists

Balanced Crystalloids Versus Normal Saline in Noncritically Ill Adults with Sickle Cell Disease Admitted from the Emergency Department: A Sub-Analysis of the Salt-ED Trial

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease

Vaccine Schedule Disparities Exist for Pediatric Patients with Sickle Cell Disease

Anticoagulation Use for Secondary Prophylaxis Against Recurrent Venous Thromboembolism in Hospitalized Children: A Report from the Children's Hospital-Acquired Thrombosis (CHAT) Consortium

Standardizing the Diagnostic and Therapeutic Approach to Newly Diagnosed Children with ITP: Prospective Data from the ITP Consortium of North America (ICON) Quality Improvement Initiative

International Survey of Secondary Thromboprophylaxis Practice Patterns in Pediatrics

Sleep Characterization of Adolescent and Young Adult Patients with Sickle Cell Disease Using the Pittsburgh Sleep Quality Index

A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Effect of Crizanlizumab and Standard of Care (SoC) Versus Standard of Care Alone on Renal Function in Patients with Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)

Quantitative Assessment of Physical Activity in Adults with Sickle Cell Disease

Outcomes of Patients with Sickle Cell Disease and Eskd in the Usrds Registry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only